Fenster schließen  |  Fenster drucken

Geron Bear V. Bull - 50¢ Or $50

May. 1.18 |
About: Geron Corporation (GERN)

Der Autor des Artikels fasst noch einmal die "Historie" der veröffentlichten Geron-Artikel von Shorties und Longies zusammen und führt am Ende entscheidende Eckpunkte einer möglichen zukünftigen ( Kurs)Enwicklung von Geron auf.


Short bears, Alpha Exposure (AE) and Adam Feurstein (AF) in the near corner, take the ~50¢ position.


1. "Geron: Imetelstat's History Of Deaths And Safety Issues" (2/09/18)

2. "Imetelstat Might Be Brought Down By Hy's Law" (2/20/18)

3."Geron's Negative Imetelstat Data Has Been Misinterpreted By Investors" (3/22/18)

4. "We Believe Janssen Has Separated From Geron. Just Awaiting Divorce Papers" (4/26/18).


Long bulls, MedTechBio (MTB) and Invest With Logic (IWL), keep their focus skyward.

Geron: It's Breakout Time" (12/6/17).

"Geron's Imetelstat Hits A Grand Slam, But The Rally Is Just Beginning" (3/21/18)

"Little Geron May Soon Be Nipping At The Heels Of Celgene And Incyte" (1/29/18).


Conclusion

I trust that readers will appreciate that Geron's future is highly uncertain.

There are those who believe it has virtually unlimited potential.....LONGIES
There are those who believe the exact opposite.......SHORTIES

I have taken the opinion that Geron offers an exceptional prospect for a near-term doubling with a further prospect of additional gains beyond that. That is enough for me to give Geron top place in my speculative pharma portfolio.


I am looking forward to the next few quarters. Questions for resolution will include:

1.Will Johnson & Johnson act on a continuation decision in Q3, as forecast?

2. Assuming it does favorably, as I do, will Geron then opt-in or opt-out.

3. Assuming Geron opts-in, as I do, will Geron then seek significant new cash either in the debt or secondary markets?

4. Once Johnson & Johnson issues a positive continuation decision, what types of FDA trial enhancements will it seek?

5. Once Johnson & Johnson issues its continuation decision, what additional imetelstat clinical trials will it and Geron pursue?


https://seekingalpha.com/article/4167828-geron-bear-v-bull-5…
 
aus der Diskussion: Geron mit Hammernews!!
Autor (Datum des Eintrages): bernie55  (01.05.18 11:43:59)
Beitrag: 2,669 von 3,090 (ID:57668400)
Alle Angaben ohne Gewähr © wallstreetONLINE